As President Donald Trump settles back into the Oval Office and January’s new Congress approaches, senior Democrats are betting that the next era of lawmaking may require what one described as a “historic deal”—and, in a surprising gesture, are angling to offer Trump his name on it.
Earlier this week, Michigan’s newly elected Senator Abdul El-Sayed introduced a proposal dubbed “TrumpCare”: a universal healthcare program featuring a gold insurance card emblazoned with the president’s name. El-Sayed argued the plan—remarkable as it is for the branding, but also for its substance—demonstrates how Democrats are willing to collaborate on issues with widespread public support, if Trump will lend his political weight to the cause (apnews.com).
Senator James Talarico of Texas sought to appeal directly to Trump’s sense of legacy, publicly suggesting the president could seize a chapter as consequential as Lyndon B. Johnson’s by partnering on sweeping policy reforms. Meanwhile, Hakeem Jeffries, set to take the speaker’s gavel in January, publicly affirmed his willingness to work with the president “wherever and whenever possible”—especially if it means legislative progress on healthcare, prescription drug prices, or economic support for the film and TV industry.
The American public appears primed for action: A Gallup and West Health poll recently found that a third of Americans have made financial sacrifices to afford healthcare (axios.com). In this climate, Democrats believe tough votes and tough negotiations can’t wait.
Obstacles in the Executive Suite
If there was any sign that hopefulness in Washington should remain cautious, it came with Trump’s choice of Stephen Miller as White House Chief of Staff. Miller’s track record as a polarizing figure has already sparked doubts among Democrats that their extended olive branches will be grasped; his divisive rhetoric and policy instincts are seen by many as antithetical to bipartisan progress.
For his part, Trump has signaled—at least for the record—that he is open to negotiating. He has stated his intention to veto initial healthcare and drug price bills out of the gate, but suggested discussions could ultimately yield compromise.
Some Democrats are taking a tougher tack. Virginia Governor Abigail Spanberger has opposed actively courting Trump, favoring instead a strategy of passing popular legislation and daring the president to block it at his own political risk. This pragmatic tone echoes a belief that, while history holds examples of Trump cutting bipartisan deals in the past, it would be unwise to assume that opportunity persists with every new cabinet appointment or talking point.
What Comes Next
The opening moves this month show the dual-track strategy unfolding: Democratic leaders broadcast their readiness to collaborate—and simultaneously brace for confrontation. With critical legislative priorities like healthcare costs, prescription drug pricing, and industry tax incentives on the docket, the question is whether personal ambition and party interest can be harnessed to move major policy. The answer may depend not only on the president’s inclinations, but on the resolve and creativity of those across the aisle determined both to achieve progress and to claim a share in its history.